{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:34:23Z","timestamp":1790778863367,"version":"4.1.0"},"update-to":[{"DOI":"10.1371\/journal.ppat.1007464","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,12,18]],"date-time":"2018-12-18T00:00:00Z","timestamp":1545091200000}}],"reference-count":64,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T00:00:00Z","timestamp":1544054400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"DOI":"10.1371\/journal.ppat.1007464","type":"journal-article","created":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T17:40:21Z","timestamp":1544118021000},"page":"e1007464","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":54,"title":["Immunogenic particles with a broad antigenic spectrum stimulate cytolytic T cells and offer increased protection against EBV infection ex vivo and in mice"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6470-4942","authenticated-orcid":true,"given":"Dwain G.","family":"van Zyl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5563-3057","authenticated-orcid":true,"given":"Ming-Han","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6332-5844","authenticated-orcid":true,"given":"Anatoliy","family":"Shumilov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktor","family":"Schneidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8171-3317","authenticated-orcid":true,"given":"R\u00e9my","family":"Poirey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"Schlehe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert","family":"Fluhr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8680-1065","authenticated-orcid":true,"given":"Josef","family":"Mautner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1744-6274","authenticated-orcid":true,"given":"Henri-Jacques","family":"Delecluse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,12,6]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"16242","DOI":"10.1073\/pnas.1418974111","article-title":"Epstein-Barr virus replicating in epithelial cells","volume":"111","author":"LM Hutt-Fletcher","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nrc1452","article-title":"Epstein-Barr virus: 40 years on","volume":"4","author":"LS Young","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"535738","DOI":"10.1155\/2013\/535738","article-title":"Epstein-Barr virus in systemic autoimmune diseases","volume":"2013","author":"AH Draborg","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1146\/annurev.mi.27.100173.002213","article-title":"The EB virus","volume":"27","author":"MA Epstein","year":"1973","journal-title":"Annu Rev Microbiol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1038\/cti.2014.27","article-title":"Epstein-barr virus vaccines","volume":"4","author":"JI Cohen","year":"2015","journal-title":"Clin Transl Immunology"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1086\/523813","article-title":"Recombinant gp350 vaccine for infectious mononucleosis: a phase 2, randomized, double-blind, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy of an Epstein-Barr virus vaccine in healthy young adults","volume":"196","author":"EM Sokal","year":"2007","journal-title":"J Infect Dis"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1093\/nar\/gky129","article-title":"Translational profiling of B cells infected with the Epstein-Barr virus reveals 5' leader ribosome recruitment through upstream open reading frames","volume":"46","author":"M Bencun","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"13585","DOI":"10.1073\/pnas.1735466100","article-title":"Reevaluation of human cytomegalovirus coding potential","volume":"100","author":"E Murphy","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"e1003847","DOI":"10.1371\/journal.ppat.1003847","article-title":"KSHV 2.0: a comprehensive annotation of the Kaposi's sarcoma-associated herpesvirus genome using next-generation sequencing reveals novel genomic and functional features","volume":"10","author":"C Arias","year":"2014","journal-title":"PLoS Pathog"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1146\/annurev-immunol-032414-112326","article-title":"The immunology of Epstein-Barr virus-induced disease","volume":"33","author":"GS Taylor","year":"2015","journal-title":"Annu Rev Immunol"},{"key":"ref11","first-page":"171","article-title":"First EBV vaccine trial in humans using recombinant vaccinia virus expressing the major membrane antigen","volume":"84","author":"SY Gu","year":"1995","journal-title":"Dev Biol Stand"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.cell.2015.07.043","article-title":"Rational Design of an Epstein-Barr Virus Vaccine Targeting the Receptor-Binding Site","volume":"162","author":"M Kanekiyo","year":"2015","journal-title":"Cell"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1128\/JVI.01409-07","article-title":"Phase I trial of a CD8+ T-cell peptide epitope-based vaccine for infectious mononucleosis","volume":"82","author":"SL Elliott","year":"2008","journal-title":"J Virol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1128\/JVI.02533-12","article-title":"An Epstein-Barr virus mutant produces immunogenic defective particles devoid of viral DNA","volume":"87","author":"S Pavlova","year":"2013","journal-title":"J Virol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"16286","DOI":"10.1073\/pnas.0407320101","article-title":"Proteins of purified Epstein-Barr virus","volume":"101","author":"E Johannsen","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"4896","DOI":"10.1128\/JVI.79.8.4896-4907.2005","article-title":"CD4+ T-cell responses to Epstein-Barr virus (EBV) latent-cycle antigens and the recognition of EBV-transformed lymphoblastoid cell lines","volume":"79","author":"HM Long","year":"2005","journal-title":"J Virol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"e583","DOI":"10.1371\/journal.pone.0000583","article-title":"Immunodominance of lytic cycle antigens in Epstein-Barr virus-specific CD4+ T cell preparations for therapy","volume":"2","author":"D Adhikary","year":"2007","journal-title":"PLoS One"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1182\/blood-2014-07-591412","article-title":"Antigen-armed antibodies targeting B lymphoma cells effectively activate antigen-specific CD4+ T cells","volume":"125","author":"X Yu","year":"2015","journal-title":"Blood"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1073\/pnas.77.5.2979","article-title":"Monoclonal antibody against a 250,000-dalton glycoprotein of Epstein-Barr virus identifies a membrane antigen and a neutralizing antigen","volume":"77","author":"GJ Hoffman","year":"1980","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"4616","DOI":"10.1128\/JVI.01613-08","article-title":"Primary B-cell infection with a deltaBALF4 Epstein-Barr virus comes to a halt in the endosomal compartment yet still elicits a potent CD4-positive cytotoxic T-cell response","volume":"83","author":"B Neuhierl","year":"2009","journal-title":"J Virol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"14257","DOI":"10.1038\/ncomms14257","article-title":"Epstein-Barr virus particles induce centrosome amplification and chromosomal instability","volume":"8","author":"A Shumilov","year":"2017","journal-title":"Nat Commun"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/imm.12106","article-title":"Detection of Epstein-Barr virus-specific memory CD4+ T cells using a peptide-based cultured enzyme-linked immunospot assay","volume":"139","author":"SA Calarota","year":"2013","journal-title":"Immunology"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"3903","DOI":"10.1128\/JVI.02227-07","article-title":"Standardized and highly efficient expansion of Epstein-Barr virus-specific CD4+ T cells by using virus-like particles","volume":"82","author":"D Adhikary","year":"2008","journal-title":"J Virol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"e1004068","DOI":"10.1371\/journal.ppat.1004068","article-title":"Virus and autoantigen-specific CD4+ T cells are key effectors in a SCID mouse model of EBV-associated post-transplant lymphoproliferative disorders","volume":"10","author":"S Linnerbauer","year":"2014","journal-title":"PLoS Pathog"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1084\/jem.20060215","article-title":"Virus-specific CD4+ T cells: ready for direct attack","volume":"203","author":"KN Heller","year":"2006","journal-title":"J Exp Med"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ejcb.2011.01.007","article-title":"The role of virus-specific CD4+ T cells in the control of Epstein-Barr virus infection","volume":"91","author":"J Mautner","year":"2012","journal-title":"Eur J Cell Biol"},{"key":"ref27","article-title":"Antibodies conjugated with viral antigens elicit a cytotoxic T cell response against primary CLL ex vivo","author":"V Schneidt","year":"2018","journal-title":"Leukemia"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"15036","DOI":"10.1073\/pnas.232381299","article-title":"Glycoprotein gp110 of Epstein-Barr virus determines viral tropism and efficiency of infection","volume":"99","author":"B Neuhierl","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.celrep.2013.09.012","article-title":"Spontaneous lytic replication and epitheliotropism define an Epstein-Barr virus strain found in carcinomas","volume":"5","author":"MH Tsai","year":"2013","journal-title":"Cell Rep"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1182\/blood-2008-03-148072","article-title":"Targeting the nuclear antigen 1 of Epstein-Barr virus to the human endocytic receptor DEC-205 stimulates protective T-cell responses","volume":"112","author":"C Gurer","year":"2008","journal-title":"Blood"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"3740","DOI":"10.1128\/JVI.75.8.3740-3752.2001","article-title":"CD4+ T-cell effectors inhibit Epstein-Barr virus-induced B-cell proliferation","volume":"75","author":"S Nikiforow","year":"2001","journal-title":"J Virol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1586\/erv.10.49","article-title":"New flow cytometric assays for monitoring cell-mediated cytotoxicity","volume":"9","author":"L Zaritskaya","year":"2010","journal-title":"Expert Rev Vaccines"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1084\/jem.191.10.1649","article-title":"Human CD4(+) T lymphocytes consistently respond to the latent Epstein-Barr virus nuclear antigen EBNA1","volume":"191","author":"C Munz","year":"2000","journal-title":"J Exp Med"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1172\/JCI10209","article-title":"EBNA1-specific CD4+ T cells in healthy carriers of Epstein-Barr virus are primarily Th1 in function","volume":"107","author":"K Bickham","year":"2001","journal-title":"J Clin Invest"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1084\/jem.20051287","article-title":"Control of Epstein-Barr virus infection in vitro by T helper cells specific for virion glycoproteins","volume":"203","author":"D Adhikary","year":"2006","journal-title":"J Exp Med"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1084\/jem.20081720","article-title":"Priming of protective T cell responses against virus-induced tumors in mice with human immune system components","volume":"206","author":"T Strowig","year":"2009","journal-title":"J Exp Med"},{"key":"ref37","first-page":"269","article-title":"Human immunity against EBV-lessons from the clinic","volume":"214","author":"SG Tangye","year":"2017"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1084\/jem.20041542","article-title":"CD8+ immunodominance among Epstein-Barr virus lytic cycle antigens directly reflects the efficiency of antigen presentation in lytically infected cells","volume":"201","author":"VA Pudney","year":"2005","journal-title":"J Exp Med"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"5398","DOI":"10.4049\/jimmunol.1301629","article-title":"CD8+ T cell responses to lytic EBV infection: late antigen specificities as subdominant components of the total response","volume":"191","author":"RJ Abbott","year":"2013","journal-title":"J Immunol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"e1005549","DOI":"10.1371\/journal.ppat.1005549","article-title":"Early T Cell Recognition of B Cells following Epstein-Barr Virus Infection: Identifying Potential Targets for Prophylactic Vaccination","volume":"12","author":"JM Brooks","year":"2016","journal-title":"PLoS Pathog"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"e1007110","DOI":"10.1371\/journal.ppat.1007110","article-title":"Proteome-wide analysis of CD8+ T cell responses to EBV reveals differences between primary and persistent infection","volume":"14","author":"C Forrest","year":"2018","journal-title":"PLOS Pathogens"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/318287a0","article-title":"Protection of cottontop tamarins against Epstein-Barr virus-induced malignant lymphoma by a prototype subunit vaccine","volume":"318","author":"MA Epstein","year":"1985","journal-title":"Nature"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12967-015-0415-2","article-title":"A chimeric EBV gp350\/220-based VLP replicates the virion B-cell attachment mechanism and elicits long-lasting neutralizing antibodies in mice","volume":"13","author":"JG Ogembo","year":"2015","journal-title":"J Transl Med"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1128\/JVI.43.2.730-736.1982","article-title":"Identification and isolation of the main component (gp350-gp220) of Epstein-Barr virus responsible for generating neutralizing antibodies in vivo","volume":"43","author":"DA Thorley-Lawson","year":"1982","journal-title":"J Virol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"7065","DOI":"10.1073\/pnas.0510512103","article-title":"Resting B cells as a transfer vehicle for Epstein-Barr virus infection of epithelial cells","volume":"103","author":"CD Shannon-Lowe","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/s41564-017-0080-8","article-title":"Ephrin receptor A2 is an epithelial cell receptor for Epstein-Barr virus entry","volume":"3","author":"H Zhang","year":"2018","journal-title":"Nature Microbiology"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/s41564-017-0081-7","article-title":"Ephrin receptor A2 is a functional entry receptor for Epstein-Barr virus","volume":"3","author":"J Chen","year":"2018","journal-title":"Nature Microbiology"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.immuni.2018.03.026","article-title":"An Antibody Targeting the Fusion Machinery Neutralizes Dual-Tropic Infection and Defines a Site of Vulnerability on Epstein-Barr Virus","volume":"48","author":"J Snijder","year":"2018","journal-title":"Immunity"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1128\/JVI.65.2.996-1001.1991","article-title":"Epstein-Barr virus (EBV) glycoprotein gp350 expressed on transfected cells resistant to natural killer cell activity serves as a target antigen for EBV-specific antibody-dependent cellular cytotoxicity","volume":"65","author":"M Khyatti","year":"1991","journal-title":"J Virol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.virol.2009.06.013","article-title":"Human antibody titers to Epstein-Barr Virus (EBV) gp350 correlate with neutralization of infectivity better than antibody titers to EBV gp42 using a rapid flow cytometry-based EBV neutralization assay","volume":"391","author":"J Sashihara","year":"2009","journal-title":"Virology"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.1182\/blood-2009-07-143545","article-title":"How I treat EBV lymphoproliferation","volume":"114","author":"HE Heslop","year":"2009","journal-title":"Blood"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1056\/NEJMra032015","article-title":"Persistence of the Epstein-Barr virus and the origins of associated lymphomas","volume":"350","author":"DA Thorley-Lawson","year":"2004","journal-title":"N Engl J Med"},{"key":"ref53","first-page":"427","article-title":"Adoptive T-Cell Immunotherapy","volume":"391","author":"S Gottschalk","year":"2015","journal-title":"Curr Top Microbiol Immunol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s12185-011-0782-2","article-title":"Immunotherapy for EBV-associated malignancies","volume":"93","author":"A Merlo","year":"2011","journal-title":"Int J Hematol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1182\/blood.V92.5.1549","article-title":"Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients","volume":"92","author":"CM Rooney","year":"1998","journal-title":"Blood"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1086\/590502","article-title":"A new humanized mouse model of Epstein-Barr virus infection that reproduces persistent infection, lymphoproliferative disorder, and cell-mediated and humoral immune responses","volume":"198","author":"M Yajima","year":"2008","journal-title":"J Infect Dis"},{"key":"ref57","first-page":"119","article-title":"Epstein-Barr Virus: From the Detection of Sequence Polymorphisms to the Recognition of Viral Types","volume":"390","author":"R Feederle","year":"2015","journal-title":"Curr Top Microbiol Immunol"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00262-018-2118-z","article-title":"Epstein-Barr virus strain heterogeneity impairs human T-cell immunity","volume":"67","author":"A Cirac","year":"2018","journal-title":"Cancer Immunology, Immunotherapy"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0140-6736(64)92345-1","article-title":"CYTOLOGY OF BURKITT'S TUMOUR (AFRICAN LYMPHOMA)","volume":"1","author":"JV Pulvertaft","year":"1964","journal-title":"Lancet"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1099\/0022-1317-36-1-59","article-title":"Characteristics of a human cell line transformed by DNA from human adenovirus type 5","volume":"36","author":"FL Graham","year":"1977","journal-title":"J Gen Virol"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1093\/nar\/gni035","article-title":"Simple and highly efficient BAC recombineering using galK selection","volume":"33","author":"S Warming","year":"2005","journal-title":"Nucleic Acids Res"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"8245","DOI":"10.1073\/pnas.95.14.8245","article-title":"Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells","volume":"95","author":"HJ Delecluse","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"10142","DOI":"10.1128\/JVI.74.21.10142-10152.2000","article-title":"Infectious Epstein-Barr virus lacking major glycoprotein BLLF1 (gp350\/220) demonstrates the existence of additional viral ligands","volume":"74","author":"A Janz","year":"2000","journal-title":"J Virol"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"e1005344","DOI":"10.1371\/journal.ppat.1005344","article-title":"The Epstein-Barr Virus BART miRNA Cluster of the M81 Strain Modulates Multiple Functions in Primary B Cells","volume":"11","author":"X Lin","year":"2015","journal-title":"PLoS Pathog"}],"updated-by":[{"DOI":"10.1371\/journal.ppat.1007464","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,12,18]],"date-time":"2018-12-18T00:00:00Z","timestamp":1545091200000}}],"container-title":["PLOS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.ppat.1007464","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T20:09:10Z","timestamp":1605557350000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1007464"}},"subtitle":[],"editor":[{"given":"Rajiv","family":"Khanna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,12,6]]},"references-count":64,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2018,12,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1007464","relation":{},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,6]]}}}